Skip navigation

Chemical Adamantane

1–50 of 69 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 12-(3-adamantan-1-ylureido)dodecanoic acid lactate dehydrogenase activity 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased lactate dehydrogenase activity 1: Homo sapiens Bronchi | Epithelial Cells | Cell Line   1
2. 12-(3-adamantan-1-ylureido)dodecanoic acid leukocyte migration involved in inflammatory response Bleomycin 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased leukocyte migration involved in inflammatory response] 1: Mus musculus Lung | Macrophages   1
3. 12-(3-adamantan-1-ylureido)dodecanoic acid cell proliferation 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased cell proliferation 1: Homo sapiens Lung | Fibroblasts | Cell Line
7 genes: BAX | LTA | SPHK2 | TGFB1 | TNF | TNFRSF1B | TP63 		1
4. 12-(3-adamantan-1-ylureido)dodecanoic acid lactate dehydrogenase activity 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased lactate dehydrogenase activity 1: Homo sapiens Lung | Fibroblasts | Cell Line   1
5. 12-(3-adamantan-1-ylureido)dodecanoic acid cell proliferation 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased cell proliferation 1: Homo sapiens Bronchi | Epithelial Cells | Cell Line
7 genes: BAX | LTA | SPHK2 | TGFB1 | TNF | TNFRSF1B | TP63 		1
6. 12-(3-adamantan-1-ylureido)dodecanoic acid negative regulation of vasoconstriction 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine 12-(3-adamantan-1-ylureido)dodecanoic acid promotes the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased negative regulation of vasoconstriction] 1: Mus musculus Aorta   1
7. 12-(3-adamantan-1-ylureido)dodecanoic acid leukocyte migration involved in inflammatory response Bleomycin 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased leukocyte migration involved in inflammatory response] 1: Mus musculus Lung | Neutrophils   1
8. 12-(3-adamantan-1-ylureido)dodecanoic acid leukocyte migration involved in inflammatory response Bleomycin 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased leukocyte migration involved in inflammatory response] 1: Mus musculus Lung | Lymphocytes   1
9. 2-aminoadamantane response to antineoplastic agent 2-aminoadamantane analog results in increased response to antineoplastic agent 1: Homo sapiens Lung | Cell Line, Tumor   1
10. 2-aminoadamantane response to antineoplastic agent Topotecan [2-aminoadamantane analog results in increased response to antineoplastic agent] which results in increased susceptibility to Topotecan 1: Homo sapiens Lung | Cell Line, Tumor   1
11. 2-aminoadamantane response to antineoplastic agent Topotecan [2-aminoadamantane analog results in increased response to antineoplastic agent] which results in increased susceptibility to Topotecan 1: Homo sapiens HCT116 Cells   1
12. 2-aminoadamantane response to antineoplastic agent 2-aminoadamantane analog results in increased response to antineoplastic agent 1: Homo sapiens HCT116 Cells   1
13. 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid apoptotic process 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid results in increased apoptotic process 1: Homo sapiens Blood | Cell Line, Tumor
6 genes: BAD | BIRC3 | CASP3 | NFKBIA | PARP1 | XIAP 		1
14. 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid cell proliferation 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid results in decreased cell proliferation 1: Homo sapiens Blood | Cell Line, Tumor 1 gene: BAD 1
15. 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid cell proliferation 3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid results in decreased cell proliferation 1: Mus musculus Breast | Cell Line, Tumor 1 gene: BAD 1
16. Amantadine locomotion Amantadine results in increased locomotion 1: Homo sapiens Leg   1
17. Amantadine locomotory exploration behavior Amantadine results in decreased locomotory exploration behavior 1: Mus musculus     1
18. Amantadine negative regulation of NMDA glutamate receptor activity Amantadine results in increased negative regulation of NMDA glutamate receptor activity     1
19. Amantadine cell death Amantadine results in decreased cell death Neurons | Cells, Cultured   1
20. Amantadine negative regulation of locomotion involved in locomotory behavior Amantadine results in increased negative regulation of locomotion involved in locomotory behavior 1: Mus musculus     1
21. Amantadine regulation of blood pressure Amantadine results in decreased regulation of blood pressure Vagus Nerve   1
22. Amantadine locomotion Amantadine results in increased locomotion 1: Homo sapiens Heel | Toes   1
23. Memantine cell death Memantine results in decreased cell death 1: Rattus norvegicus Retinal Ganglion Cells   1
24. Memantine positive regulation of apoptotic process Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of apoptotic process] 1: Rattus norvegicus Neocortex
3 genes: CASP3 | CREB1 | TNF 		1
25. Memantine positive regulation of apoptotic process Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of apoptotic process] 1: Rattus norvegicus Hippocampus
3 genes: CASP3 | CREB1 | TNF 		1
26. Memantine positive regulation of cytosolic calcium ion concentration Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of cytosolic calcium ion concentration] 1: Rattus norvegicus Neocortex | Synaptosomes 1 gene: DLG4 1
27. Memantine positive regulation of cytosolic calcium ion concentration Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of cytosolic calcium ion concentration] 1: Rattus norvegicus Hippocampus | Synaptosomes 1 gene: DLG4 1
28. Memantine excitatory postsynaptic potential methylatropine | Paraoxon [Memantine co-treated with methylatropine] inhibits the reaction [Paraoxon affects excitatory postsynaptic potential] 1: Mus musculus Hippocampus | Pyramidal Cells   1
29. Memantine positive regulation of succinate dehydrogenase activity Streptozocin Memantine inhibits the reaction [Streptozocin results in decreased positive regulation of succinate dehydrogenase activity] 1: Rattus norvegicus Neocortex | Synaptosomes | Mitochondria   1
30. Memantine positive regulation of succinate dehydrogenase activity Streptozocin Memantine inhibits the reaction [Streptozocin results in decreased positive regulation of succinate dehydrogenase activity] 1: Rattus norvegicus Hippocampus | Synaptosomes | Mitochondria   1
31. Memantine regulation of neuronal action potential methylatropine | Paraoxon [Memantine co-treated with methylatropine] inhibits the reaction [Paraoxon affects regulation of neuronal action potential] 1: Mus musculus Hippocampus   1
32. Memantine positive regulation of reactive oxygen species biosynthetic process Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of reactive oxygen species biosynthetic process] 1: Rattus norvegicus Hippocampus | Synaptosomes   1
33. Memantine excitatory postsynaptic potential Paraoxon Memantine inhibits the reaction [Paraoxon affects excitatory postsynaptic potential] 1: Mus musculus Hippocampus | Pyramidal Cells   1
34. Memantine astrocyte activation Streptozocin Memantine inhibits the reaction [Streptozocin results in increased astrocyte activation] 1: Rattus norvegicus Cerebral Cortex 1 gene: APP 1
35. Memantine positive regulation of reactive oxygen species biosynthetic process Streptozocin Memantine inhibits the reaction [Streptozocin results in increased positive regulation of reactive oxygen species biosynthetic process] 1: Rattus norvegicus Neocortex | Synaptosomes   1
36. Memantine regulation of resting membrane potential Paraoxon Memantine inhibits the reaction [Paraoxon affects regulation of resting membrane potential] 1: Mus musculus Hippocampus   1
37. Memantine head development O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate Memantine inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased head development] 1: Danio rerio Head   1
38. Memantine regulation of neuronal action potential Paraoxon Memantine inhibits the reaction [Paraoxon affects regulation of neuronal action potential] 1: Mus musculus Hippocampus   1
39. N-(1-adamantyl)-1-pentylindazole-3-carboxamide drug metabolic process NAD [NAD results in increased drug metabolic process] which results in increased oxidation of N-(1-adamantyl)-1-pentylindazole-3-carboxamide metabolite 1: Homo sapiens Liver | Cytosol   1
40. NSC 680410 apoptotic process Bortezomib Bortezomib promotes the reaction [NSC 680410 results in increased apoptotic process] 1: Mus musculus Bone Marrow | Cell Line
15 genes: ABL1 | AIFM1 | AKT1 | CASP3 | CASP8 | CASP9 | CYCS | DIABLO | MAPK1 | MAPK14 | MAPK3 | PARP1 | RAF1 | RB1 | RPS6KB1 		1
41. NSC 680410 response to oxidative stress Acetylcysteine | Bortezomib Acetylcysteine inhibits the reaction [Bortezomib promotes the reaction [NSC 680410 results in increased response to oxidative stress]] 1: Mus musculus Bone Marrow | Cell Line
5 genes: ABL1 | AIFM1 | AKT1 | CYCS | MAP2K1 		1
42. NSC 680410 apoptotic process Acetylcysteine | Bortezomib Acetylcysteine inhibits the reaction [Bortezomib promotes the reaction [NSC 680410 results in increased apoptotic process]] 1: Mus musculus Bone Marrow | Cell Line
15 genes: ABL1 | AIFM1 | AKT1 | CASP3 | CASP8 | CASP9 | CYCS | DIABLO | MAPK1 | MAPK14 | MAPK3 | PARP1 | RAF1 | RB1 | RPS6KB1 		1
43. NSC 680410 apoptotic process NSC 680410 results in increased apoptotic process 1: Mus musculus Bone Marrow | Cell Line
15 genes: ABL1 | AIFM1 | AKT1 | CASP3 | CASP8 | CASP9 | CYCS | DIABLO | MAPK1 | MAPK14 | MAPK3 | PARP1 | RAF1 | RB1 | RPS6KB1 		1
44. NSC 680410 response to oxidative stress Bortezomib Bortezomib promotes the reaction [NSC 680410 results in increased response to oxidative stress] 1: Mus musculus Bone Marrow | Cell Line
5 genes: ABL1 | AIFM1 | AKT1 | CYCS | MAP2K1 		1
45. NSC 680410 response to oxidative stress Acetylcysteine Acetylcysteine inhibits the reaction [NSC 680410 results in increased response to oxidative stress] 1: Mus musculus Bone Marrow | Cell Line
5 genes: ABL1 | AIFM1 | AKT1 | CYCS | MAP2K1 		1
46. NSC 680410 response to oxidative stress NSC 680410 results in increased response to oxidative stress 1: Mus musculus Bone Marrow | Cell Line
5 genes: ABL1 | AIFM1 | AKT1 | CYCS | MAP2K1 		1
47. saxagliptin regulation of dopamine metabolic process Dopamine | Rotenone saxagliptin inhibits the reaction [[Rotenone affects regulation of dopamine metabolic process] which results in decreased abundance of Dopamine] 1: Rattus norvegicus Corpus Striatum   1
48. saxagliptin lipid oxidation Rotenone | Thiobarbituric Acid Reactive Substances saxagliptin inhibits the reaction [[Rotenone results in increased lipid oxidation] which results in increased abundance of Thiobarbituric Acid Reactive Substances] 1: Rattus norvegicus Corpus Striatum   1
49. saxagliptin regulation of dopamine metabolic process Rotenone saxagliptin inhibits the reaction [Rotenone affects regulation of dopamine metabolic process] 1: Rattus norvegicus Corpus Striatum   1
50. saxagliptin cAMP metabolic process Rotenone saxagliptin inhibits the reaction [Rotenone affects cAMP metabolic process] 1: Rattus norvegicus Corpus Striatum   1
1–50 of 69 results.
Download: CSV| Excel| XML| TSV